NCT06711276 Accuracy of the New Injury Severity Score in Evaluating Patients With Blunt Trauma
| NCT ID | NCT06711276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Al-Nahrain University |
| Condition | Trauma |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2025-01-10 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2025-01-10 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective observational study is to evaluate the predictive utility of the New Injury Severity Score (NISS) in determining mortality outcomes among blunt trauma patients admitted to the Emergency Department of Kadhimiya Educational Hospital, Iraq. The main questions it aims to answer are: How accurately does NISS predict mortality in blunt trauma patients? What is the performance of NISS in predicting secondary outcomes, such as the need for intensive care and length of hospital stay? Participants will: Be assessed using the NISS score upon their admission to the emergency department. Have their clinical outcomes, including mortality, need for intensive care, and hospital stay, monitored throughout their hospitalization.
Eligibility Criteria
Inclusion Criteria: * Trauma patients admitted to the emergency department, presenting with blunt trauma, such as from motor vehicle accidents, falls, or assaults. * Patients with adequate documentation of anatomical injuries and physiological parameters required for NISS calculation. * Injury assessment and NISS calculation completed within the first 6 hours of arrival to ensure accuracy and consistency in trauma evaluation. Exclusion Criteria: * Patients under 18 years, pregnant women, or those with pre-existing medical conditions that may alter trauma scoring accuracy or management outcomes. * Patients presenting with medical emergencies, terminal illnesses, or conditions unrelated to blunt trauma to ensure focus on trauma-specific evaluations. * Patients declared dead on arrival or who do not receive active treatment in the emergency department. * Patients or their families refusing participation or withdrawing consent at any stage of the study. * Patients transferred from or to another facility or those previously treated elsewhere, as this may affect data collection and scoring reliability.
Contact & Investigator
Rawa'a A. Sattar A. Wahhab, MBBCH FICS CABMS FACS
STUDY DIRECTOR
College Of Medicine - Nahrain University
Frequently Asked Questions
Who can join the NCT06711276 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Trauma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06711276 currently recruiting?
Yes, NCT06711276 is actively recruiting participants. Contact the research team at allaabed987@ced.nahrainuniv.edu.iq for enrollment information.
Where is the NCT06711276 trial being conducted?
This trial is being conducted at Baghdad, Iraq.
Who is sponsoring the NCT06711276 clinical trial?
NCT06711276 is sponsored by Al-Nahrain University. The principal investigator is Rawa'a A. Sattar A. Wahhab, MBBCH FICS CABMS FACS at College Of Medicine - Nahrain University. The trial plans to enroll 210 participants.